Leitao Mario M, Natenzon Anna, Abu-Rustum Nadeem R, Chi Dennis S, Sonoda Yukio, Levine Douglas A, Gardner Ginger J, Barakat Richard R
Division of Gynecology, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Gynecol Oncol. 2009 Nov;115(2):204-8. doi: 10.1016/j.ygyno.2009.08.005. Epub 2009 Sep 8.
To determine whether HA-CMC was associated with the development of postoperative intra-abdominal collections in patients undergoing laparotomy for ovarian, fallopian tube, or primary peritoneal malignancies.
We retrospectively identified all laparotomies performed for these malignancies from March 1, 2005 to December 31, 2007. The use of HA-CMC was identified. Laparotomies for malignant bowel obstruction or repair of fistulae were excluded. Intra-abdominal collections, non-infected and infected, were defined as localized intraperitoneal fluid accumulations in the absence of re-accumulating ascites. All other complications were also captured. Appropriate statistical tests were applied using SPSS 15.0.
We identified 219 laparotomies with HA-CMC and 204 without HA-CMC. Upper abdominal resections were performed in 65/219 (30%) HA-CMC cases compared to 39/204 (19%) cases without HA-CMC (P=0.01). The rates of large bowel and/or rectal resections were similar in both cohorts. Intra-abdominal collections were seen in 18/219 (8.2%) HA-CMC cases compared to 5/204 (2.5%) cases without HA-CMC (P=0.009). HA-CMC was independently associated with the diagnosis of a postoperative intra-abdominal collection (P=0.01). All but 2 collections developed in patients undergoing debulking procedures.
HA-CMC appears to be associated with a higher rate of postoperative intra-abdominal collections. This seems to be greatest in patients who are undergoing a debulking procedure.
确定透明质酸-羧甲基纤维素(HA-CMC)与接受卵巢、输卵管或原发性腹膜恶性肿瘤剖腹手术患者术后腹腔内积液的发生是否相关。
我们回顾性确定了2005年3月1日至2007年12月31日期间因这些恶性肿瘤进行的所有剖腹手术。确定了HA-CMC的使用情况。排除恶性肠梗阻或瘘管修复的剖腹手术。腹腔内积液,包括非感染性和感染性,定义为在无再积聚腹水情况下的局限性腹腔内液体聚集。还记录了所有其他并发症。使用SPSS 15.0进行适当的统计检验。
我们确定了219例使用HA-CMC的剖腹手术和204例未使用HA-CMC的剖腹手术。在使用HA-CMC的219例病例中有65例(30%)进行了上腹部切除术,而未使用HA-CMC的204例病例中有39例(19%)进行了上腹部切除术(P=0.01)。两个队列中大肠和/或直肠切除术的发生率相似。使用HA-CMC的219例病例中有18例(8.2%)出现腹腔内积液,而未使用HA-CMC的204例病例中有5例(2.5%)出现腹腔内积液(P=0.009)。HA-CMC与术后腹腔内积液的诊断独立相关(P=0.01)。除2例积液外,所有积液均发生在进行减瘤手术的患者中。
HA-CMC似乎与术后腹腔内积液的发生率较高相关。这在进行减瘤手术的患者中似乎最为明显。